A2XO34 Stock Overview
Develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Axon Enterprise, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$139.02 |
52 Week High | US$144.34 |
52 Week Low | US$62.05 |
Beta | 0.94 |
11 Month Change | 8.68% |
3 Month Change | 52.33% |
1 Year Change | 134.40% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 238.41% |
Recent News & Updates
Recent updates
Shareholder Returns
A2XO34 | BR Aerospace & Defense | BR Market | |
---|---|---|---|
7D | -1.3% | -1.8% | -1.9% |
1Y | 134.4% | 32.9% | 3.3% |
Return vs Industry: A2XO34 exceeded the BR Aerospace & Defense industry which returned 32.9% over the past year.
Return vs Market: A2XO34 exceeded the BR Market which returned 3.3% over the past year.
Price Volatility
A2XO34 volatility | |
---|---|
A2XO34 Average Weekly Movement | 7.7% |
Aerospace & Defense Industry Average Movement | 6.4% |
Market Average Movement | 4.4% |
10% most volatile stocks in BR Market | 8.9% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: A2XO34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine A2XO34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 3,330 | Rick Smith | www.axon.com |
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Axon Enterprise, Inc. Fundamentals Summary
A2XO34 fundamental statistics | |
---|---|
Market cap | R$188.91b |
Earnings (TTM) | R$1.71b |
Revenue (TTM) | R$10.63b |
110.7x
P/E Ratio17.8x
P/S RatioIs A2XO34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A2XO34 income statement (TTM) | |
---|---|
Revenue | US$1.81b |
Cost of Revenue | US$727.64m |
Gross Profit | US$1.08b |
Other Expenses | US$792.26m |
Earnings | US$290.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
Earnings per share (EPS) | 3.85 |
Gross Margin | 59.81% |
Net Profit Margin | 16.05% |
Debt/Equity Ratio | 35.2% |
How did A2XO34 perform over the long term?
See historical performance and comparison